oasis-1 oral semaglutide 50 mg obesity nejm 2023 🚨 25 delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - A newly approved 7.2-mg dose

Researchers analyzed more than 142,000 patient cases involving individuals with obesity or Type 2 diabetes, according to the study

Studies showed that the presence of glycodendrons enhanced the stability of HADD and promoted the accumulation in breast cancer tumors

Cytoprotection of different cell types, including cardiomyocytes, is among the pleiotropic actions reported for GLP-1

Employers considering ways to add or adjust weight management support, with or without GLP-1s, can reflect the lower list price in budget and design decisions

2- Improved Mood and Mental Clarity B12 is crucial in producing neurotransmitters like serotonin and dopamine, which boost mood

Summary: Keeping Weight Off After GLP1 Therapy Many people regain weight when they stop GLP1 medications like semaglutide or tirzepatide